Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer

Interventions for cognitive deficits in patients with a brain tumor: an update

“…Another issue that is commonly encountered in many studies of cognitive functioning in chronically ill patients is the discrepancy observed between the subjective (self-report) and objective (neuropsychological testing) measures of cognitive functioning [75][76][77][78][79][80][81]. The results of our trial suggest that this disconnect between subjective experience and test-based indicators of cognitive functioning not only applies in cross-sectional assessments, but also in assessing change in cognitive functioning over time.…”

“…Thus, the cause of the discrepancy may be found in the perceptions of patients themselves. In fact, it has been generally observed that self-reported cognitive functioning tends to correlate more highly with self-reported measures of emotional distress and well-being than with objective neuropsychological test performance [75,76,78,80,81].…”

Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress

“…They found that 19% of the patients reported worsening of CF 2 years after chemotherapy compared to the pretreatment level; however, comparison with TCPs not treated with chemotherapy was unavailable. In a cross-sectional study of 182 TCPs assessed at a median of 3 years after end of treatment, Schagen et al [15] observed that approximately one-third of the TCPs in all treatment groups [chemotherapy, radiotherapy, and surveillance (no additional treatment after surgery)] reported some cognitive problems. As for breast cancer patients, self-reported cognitive problems were associated with psychological distress and fatigue, but not with reduced neuropsychological test performance.…”

Impact of Treatments to Improve Cognitive Function and Quality of Life on Cancer Patients with Carcinoma of the Testes

“…Kým merania psychomotorického tempa boli spojené s depresiou a anxietou, žiadne kognitívne domény neboli spojené s emocionálnym distresom, s časom od operácie, so štádiom ochorenia alebo s hladinou α-fetoproteínu, laktátdehydrogenázy, ľudského choriogonadotropínu a testosterónu [8]. Schagen et al [9] uvád-zajú na základe použitia neuropsychologickej batérie testov (dotazníka EORTC QLQ-C30, dotazníka úzkosti a depresie HSCL-25 a dotazníka únavy MFI-20) kognitívne dysfunkcie len u 5,5 % pa cientov s rakovinou semenníkov (n = 70), ktorí boli testovaní v priemere tri roky po operácii a neabsolvovali ďal-šiu adjuvantnú terapiu.…”